| Turkey | Thailand | ||
| Symptomatic treatment | from AUD $433 | from AUD $288 | from AUD $1,730 |
Dr Bugra Cetin is a board-certified urological surgeon and PhD in Molecular Medicine specialising in advanced cellular therapies and minimally invasive kidney surgery.
Associate Professor Basri Cakiroglu is a senior urologist at Hisar Hospital Intercontinental with a strong focus on endourology and kidney health.
Dr. Ilker Tinay is an urological oncologist at Anadolu Medical Center. He sits on the Executive Board of the Association of Urooncology. Dr. Tinay specializes in minimally invasive surgery and neo-bladder reconstruction. He works at Anadolu, a Top 10 global hospital according to MTQUA. The center is also affiliated with Johns Hopkins Medicine.
Dr. Abdulmuttalip Simsek is a urological surgeon at Memorial Bahçelievler Hospital in Istanbul. He specializes in robotic and reconstructive surgery for complex urological conditions. Dr. Simsek holds the rank of Professor and completed reconstructive urology training in the UK. He treats a wide range of cancers including kidney, prostate, and bladder malignancies.
Turkish JCI-accredited centres provide comprehensive care for polycystic kidney disease (PKD). They use robotic cyst decompression, dialysis, and kidney transplantation. Specialist urologists manage symptoms through medication or minimally invasive surgery. Clinics in Istanbul report organ transplant success rates of up to 90%.
Bookimed Expert Insight: Many view PKD as a general urology issue. However, Turkey's university hospitals integrate nephrology with transplant teams. Clinics such as Anadolu Medical Center follow international protocols through their affiliation with Johns Hopkins. This collaboration allows high-volume centres to manage 65,000+ annual patients while maintaining high success rates.
Patient Consensus: Patients in Turkey describe the care as highly professional. They note that hospitals are exceptionally clean and provide excellent translator support. They value the streamlined process from initial examinations through to airport transfers after treatment.
International patients are eligible for kidney transplants in Turkey for polycystic kidney disease. These typically occur through living-donor programs. JCI-accredited hospitals in Istanbul and Ankara provide renal transplantation. Leading centres report success rates reaching 90% for organ transplant procedures while serving patients from over 160 countries.
Bookimed Expert Insight: Turkish transplantation law requires international patients to bring their own living donor. Our data shows that top university hospitals like Lokman Hekim in Ankara manage high-volume transplant departments. These specialise in complex genetic cases. Patients should prioritise clinics with JCI certification and established international departments. These centres typically include the legal paperwork and ethical committee approvals required for foreign donor-recipient pairs.
Patient Consensus: Patients note the importance of bringing full nephrology records. They appreciate the high level of specialist expertise. They highlight that success depends on finding a legitimate hospital that handles all legal donor documentation. These clinics also provide dedicated translators for medical appointments in Turkey.
Recovery after a kidney transplant for polycystic kidney disease in Turkey involves a 4–10 day hospital stay. International patients usually remain in Turkey for 4–6 weeks for post-operative monitoring. Most patients return to light activities within six weeks of surgery.
Bookimed Expert Insight: Turkish transplant centres like Memorial Şişli Hospital report 90% organ transplant success rates. Centres like Memorial Bahçelievler provide eco-friendly designs to aid psychological recovery. Choosing a JCI-accredited facility meets international safety standards during the critical 6-week monitoring phase.
Patient Consensus: Patients in Turkey highlight that fatigue is the main challenge during the first month. They note the first 2 weeks require discipline regarding medication timing and hydration.
Australian patients choose Turkey for Polycystic Kidney Disease (PKD) to access rapid specialist consultations and imaging. They can avoid long public wait times. Leading JCI-accredited centres in Istanbul and Ankara provide multidisciplinary care. This includes symptomatic management, minimally invasive procedures, and organ transplantation with reported 90% success rates.
Bookimed Expert Insight: Many centres focus on general urology. However, Australians should target Turkish university-affiliated hospitals for PKD. These institutions, such as Lokman Hekim University Ankara Hospital, often house 80+ ICU beds and specialised transplant units. This infrastructure is vital because PKD management eventually requires surgical capabilities that smaller boutique clinics cannot provide.
Patient Consensus: Patients note the relief of getting immediate scans and diagnoses. They appreciate the comfort of hospital facilities in Istanbul and the smooth airport transfers provided by staff.
Several JCI-accredited medical centres in Turkey specialise in nephrology and polycystic kidney disease treatment. Facilities such as Anadolu Medical Center and Memorial Bahçelievler Hospital provide renal imaging and diagnostic genetic consultations. Specialists here focus on conserving kidney function and managing complications.
Bookimed Expert Insight: Bookimed data shows that Australian patients often choose multi-specialty centres like Valued Med Hub Hospitals. These larger institutions are preferred because polycystic kidney disease often requires multidisciplinary care. Successful outcomes rely on having nephrology, genetics, and transplant teams in one facility.
Patient Consensus: Patients note Turkey is a reliable destination for kidney care in large tertiary hospitals. They emphasise looking for teams that offer long-term monitoring and renal imaging. People appreciate the support, including translators and airport transfers, which makes the diagnostic process smoother.